International Conference on Medicinal Chemistry and Peptide Therapeutics
ICMCPT
Official Invitation Letter Available
An official invitation letter will be provided upon successful registration for your participation in the conference.
Benefits of Registering as Listener
Access to All Conference Sessions
Plenary, keynote and parallel sessions
Networking Opportunities
Connect with global educators & researchers
Certificate of Participation
Digital certificate of participation
Invitation Letter Support
Official invitation letter after successful registration
Conference Kit / Digital Materials
E-proceedings & resource materials
Access to Keynote Sessions
Learn from leading experts & scholars
Conference Session Tracks
Aligned with UN Sustainable Development Goals
The conference's session tracks effectively support the following SDGs.
This track focuses on the latest innovations in peptide-based therapies, including their design, synthesis, and application in clinical settings. Discussions will encompass the challenges and successes in translating peptide therapeutics from the laboratory to the clinic.
SDG 3
SDG 4
This session will explore the role of molecular modeling techniques in the identification and optimization of drug candidates. Participants will discuss computational approaches that enhance the understanding of drug-receptor interactions and lead to more effective therapeutic agents.
SDG 3
SDG 9
This track highlights the intersection of chemical biology and medicinal chemistry, focusing on the use of chemical tools to probe biological systems. Presentations will cover innovative methodologies that facilitate the discovery of new therapeutic targets and agents.
SDG 3
SDG 9
This session will delve into novel synthetic strategies and methodologies that advance the field of medicinal chemistry. Emphasis will be placed on the development of efficient and sustainable approaches for the synthesis of bioactive compounds.
SDG 12
This track will examine the pharmacological properties of peptide therapeutics, including their mechanisms of action, pharmacokinetics, and pharmacodynamics. Discussions will focus on how these properties influence the design and efficacy of peptide drugs.
SDG 3
SDG 9
This session aims to bridge the gap between laboratory research and clinical application in the field of medicinal chemistry. Participants will share insights on strategies to enhance the translational potential of drug candidates.
SDG 3
SDG 9
This track will cover cutting-edge laboratory techniques employed in the drug development process, from initial screening to preclinical testing. Emphasis will be placed on methodologies that improve the efficiency and accuracy of drug evaluation.
SDG 9
SDG 12
This session will focus on innovative approaches to drug design that address unmet medical needs. Presentations will highlight case studies of successful therapeutic innovations and the underlying principles that guided their development.
SDG 3
SDG 9
This track will explore advanced techniques for peptide synthesis and modification, including solid-phase synthesis and post-translational modifications. Discussions will emphasize the impact of these techniques on the biological activity and stability of peptide therapeutics.
SDG 3
SDG 9
This session will highlight emerging trends and future directions in the field of medicinal chemistry. Participants will discuss the implications of new technologies and methodologies on drug discovery and development.
SDG 3
SDG 9
This track will focus on integrative approaches that combine chemical biology and medicinal chemistry to enhance drug discovery efforts. Presentations will showcase interdisciplinary collaborations that lead to novel therapeutic strategies.
SDG 3
SDG 9